Covered recipient · General Payments record
GRAZELDA KWAKYE-ACKAH
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,350.03
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $320.07 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $85.47 | 4 |
| Biogen, Inc. | $80.78 | 4 |
| Exeltis, USA Inc. | $48.65 | 3 |
| Organon LLC | $37.66 | 2 |
| VERTEX PHARMACEUTICALS INCORPORATED | $24.50 | 1 |
| Hologic Sales and Service, LLC | $24.08 | 1 |
| INTUITIVE SURGICAL, INC. | $18.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $14.37 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139311836 | CMS |
| Astellas Pharma US Inc | $23.69 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139361755 | CMS |
| Astellas Pharma US Inc | $18.97 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139376858 | CMS |
| Astellas Pharma US Inc | $28.44 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139439932 | CMS |
| Biogen, Inc. | $16.61 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104808289 | CMS |
| Biogen, Inc. | $18.55 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104820460 | CMS |
| Biogen, Inc. | $25.75 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104822700 | CMS |
| Biogen, Inc. | $19.87 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104844664 | CMS |
| Exeltis, USA Inc. | $17.54 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149997342 | CMS |
| Exeltis, USA Inc. | $16.67 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149997344 | CMS |
| Exeltis, USA Inc. | $14.44 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149997346 | CMS |
| Hologic Sales and Service, LLC | $24.08 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084893933 | CMS |
| INTUITIVE SURGICAL, INC. | $18.93 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137143591 | CMS |
| Organon Llc | $16.24 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136215602 | CMS |
| Organon Llc | $21.42 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136215606 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $24.50 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105914556 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.